Intensive Care of the Myasthenic Patient
Neurol 48 (Suppl 5) :S70-S75997., Mayer,S.A., 1997
The Use of Self Infused IVIG Home Therapy in Trtm of Acquired Chronic Demyel Neuropathies
JNNP 63:106-109, Sewell,W.A.C.,et al, 1997
Intravenous IgG in Guillain-Barre Syndrome
BMJ 313:376-377, Hughes,R.A.C., 1996
Lyme Radiculoneuritis Treated with Intravenous Immunoglobin
Neurol 46:1174-1175, Crisp,D.&Ashby,P., 1996
Effects of Intravenous Immunoglobulin on Muscle Weakness & Calcium-Channel Autoantibodies in Lambert-Eaton Myasthenic Synd
Neurol 47:678-683, Bain,P.G.,et al, 1996
Intravenous Immunoglobin Treatment in Paraneoplastic Neurological Syndromes with Antineuronal Autoantibodies
JNNP 60:388-392, Uchuya,M.,et al, 1996
Acute Paresis of Extraocular Muscles Associated with IgG Anti-GQ Antibody
Ann Neurol 39:668-672, Yuki,N., 1996
Multifocal Motor Neuropathy
JNNP 60:599-603, Nobile-Orazio,E., 1996
Chronic Inflammatory Demyelinating Polyradiculoneuropathy:Unusual Clinical Features and Therapeutic Responses
Neurol 46:1206-1212, Midroni,G.&Dyck,P.J., 1996
Epstein-Barr Virus-Associated Acute Autonomic Neuropathy
Ann Neurol 40:453-455, Bennett,J.L.,et al, 1996
Intravenous Gammaglobulin Therapy in Recurrent Acute Disseminated Encephalomyelitis
Neurol 46:1173-1174, Hahn,J.S.,et al, 1996
Complications of Intravenous Immune Globulin Treatment in Neurologic Disease
Neurol 47:674-677, Brannagan III,T.H.,et al, 1996
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Complications of Intravenous Gammaglobulin in Neuromuscular and other Disease
Muscle & Nerve 19:388-391996., Bertorini,T.E.,et al, 1996
Treatment of Opsoclonus-Myoclonus with High-Dose Intravenous Immunoglobulin
Neurol 46:583-584, Pless,M.,et al, 1996
Treatment of Vogt-Koyanagi-Herada Syndrome with Intravenous Immunoglobulin
Neurol 46:584-585, Helveston,W.R.&Gilmore,R., 1996
Multifocal Motor Neuropathy with Conduction Block and Campylobacter Jejuni
Neurol 46:562-563, White,J.R.,et al, 1996
Idiopathic Dysautonomia Treated with Intravenous Gammaglobulin
Lancet 347:28-29, Heafield,M.T.E.,et al, 1996
Reversible Encephalopathy with Cerebral Vasospasm in a Guillain-Barre Syndrome Patient Treated with Intravenous Immunoglobulin
Neurol 46:250-251, Voltz,R.,et al, 1996
Liver Function Disturbances in Guillain-Barre Syndrome:A Prospective Longitudinal Study in 100 Patients
Neurol 46:96-100, Oomes,P.G.,et al, 1996
Pilot Trial of Immunoglobulin Versus Plasma Exchange in Patients with Guillain-Barre Syndrome
Neurol 46:100-103, Bril,V.,et al, 1996
A Controlled Study of Intravenous Immunoglobulin in Demyelinating Neuropathy with IgM Gammopathy
Ann Neurol 40:792-795, Dalakas,M.C.,et al, 1996
Successful Treatment of Neuropathies in Patients with Diabetes Mellitus
Arch Neurol 52:1053-1061, Krendel,D.A.,et al, 1995
Common Variable Immunodeficiency and Inclusion Body Myositis:A Distinct Myopathy Mediated by Natural Killer Cells
Ann Neurol 37:806-810, Dalakas,M.C.&Illa,I., 1995
Neuroblastoma-Associated Opsoclonus-Myoclonus Treated with IVIgG
J Pediatr 127:328-329, Petruzzi,M.J.&deAlarcon,P.A., 1995
Improvement of Multifocal Motor Neuropathy During Long-Term Weekly Treatment with Human Immunoglobulin
Neurol 45:987-988, van den Berg,L.H.,et al, 1995
Multifocal Motor Neuropathy with Conduction Block:A Study of 24 Patients
JNNP 59:38-44, Bouche,P.,et al, 1995
The Restoration of IVIg Efficacy by Plasma Exchange in CIDP
Neurol 45:1628-1629, Berger,A.R.,et al, 1995
Microangiopathy of the Brain and Retina (Susac's Syndrome) :Two Patients with Atypical Features
Neurol 45:1225-1226, Vila,N.,et al, 1995
Recommendations for Off-Label Use of Intravenously Administered Immunoglobulin Preparations
JAMA 273:1865-1870, Ratko,T.A.,et al, 1995
Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
A Plasma Exchange Versus Immune Globulin Infusion Trial in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Ann Neurol 36:838-845, Dyck,P.J.,et al, 1994
Treatment of Stiff-Man Syndrome with Intravenous Immunoglobulin
Neurol 44:1652-1654, Amato,A.A.,et al, 1994
Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy:Frequency and Risk Factors
Ann Int Med 121:259-262, 3051994., Sekul,E.A.,et al, 1994
Cerebral Infarction Following Intravenous Immunoglobulin Therapy for Myasthenia Gravis
Neurol 44:1180-1181, Steg,R.E.&Lefkowitz,D.M., 1994
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
Treatment of Guillain-Barre Syndrome with High-Dose Immune Globulins-Combined with Methylprednisolone:Dutch Guillain-Barre Study Group
Ann Neurol 35:749-752, , 1994
Med Trtm of Rasmussen's Syndrome (Chronic Enceph & Epilepsy) :High-Dose Steroids or Immunoglobulins in 19 Pts
Neurol 44:1030-1036, Hart,Y.M.,et al, 1994
Reversal of Subacute Paraneoplastic Cerebellar Syndrome with Intravenous Immunoglobulin
Neurol 44:1184-1185, Counsell,C.E.,et al, 1994
High-Dose Intravenous Immunoglobulin and Serum Viscosity:Risk of Precipitating Thromboembolic Events
Neurol 44:223-226, Dalakas,M., 1994
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
Intravenous Immunoglobulin Trtm in Pts with Motor Neuron Syndromes Assoc with Anti-GM Antibodies:A Contrld Study
Neurol 44:429-432, Azulay,J-P.,et al, 1994
High-Dose Intravenous Immunoglobulin Therapy in Chronic Progressive Lumbosacral Plexopathy
Neurol 44:248-250, Verma,A.&Bradley,W.G., 1994
Clinicopath Conf
Acquired Demyelinating Neuropathy, ? CIDP, ? Motor Neuropathy with Multifocal Conduction Blocks, Cas, 41-1EJM 329:1182-1190,1993., 1993
Recurrent Migraine and Intravenous Immune Globulin Therapy
NEJM 329:583-584, Constantinescu,C.S.,et al, 1993
Relapse in Guillain-Barre Syndrome after Treatment with Human Immune Globulin
Neurol 43:872-875, 8571993., Inrani,D.N.,et al, 1993
Human Immune Globulin Infusion in Guillain-Barre Syndrome:Worsening During & After Treatment
Neurol 43:1034-1036, 8571993., Castro,L.H.M.&Ropper,A.H., 1993
Myasthenic Crisis Response to Plasmapheresis Following Failure of Intravenous Gammaglobulin
Arch Neurol 50:837-840, Stricker,R.B.,et al, 1993
Treatment of Inclusion-Body Myositis with High-Dose Intravenous Immunoglobulin
Neurol 43:876-879, Soueidan,S.A.&Dalakas,M.C., 1993